Teleflex stock price target raised to $135 from $130 at RBC Capital
Investing.com - Biogen reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Biogen announced earnings per share of $4.77 on revenue of $2.78B. Analysts polled by Investing.com EPS of $4.12 on revenue of $2.67B.
Biogen 's are up 9% and is trading at $268.13 , still down 42.73% from its 52 week high of $468.20 set on Monday, June 7, 2021.
Biogen follows other major Healthcare sector earnings this month
Biogen's report follows an earnings beat by J&J on Tuesday, who reported EPS of $2.6 on revenue of $23.34B, EPS of $2.36 on revenue of $23.66B.
Intuitive Surgical had beat expectations on Tuesday with third quarter EPS of $1.19 on revenue of $1.4B, for EPS of $1.17 on revenue of $1.39B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar